Ignite Creation Date:
2024-05-06 @ 3:05 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04519788
Status:
COMPLETED
Last Update Posted:
2021-01-19
First Post:
2020-08-14
Brief Title:
AT-301 Nasal Spray in Healthy Adults
Sponsor:
Atossa Therapeutics Inc
Organization:
Atossa Therapeutics Inc
Study Overview
Official Title:
A Double-blinded Randomised and Placebo-controlled Safety Study of AT-301 Nasal Spray in Healthy Adults
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind placebo-controlled ascending dose multi-cohort study The study will be conducted in 2 parts a single ascending dose SAD part Part 1 followed by a multiple ascending dose MAD part Part 2
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None